A Phase 2 Clinical Investigation of Pyridoxamine (Pyrdorin) in Type 1 and Type 2 Diabetic Patients with Overt Diabetic Nephropathy (PYR-205/207). (Abstract). - McGill,J.B.; Williams,M.E.; Degenhardt,T.P.; Szabo,J.R.; Scotzinger,R.J. (J Am Soc Nephrol, 2004)